| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000031316 |
| Receipt No. | R000035747 |
| Scientific Title | Evaluation of limb muscle and diaphragm atrophy in critically ill patients |
| Date of disclosure of the study information | 2018/02/15 |
| Last modified on | 2020/08/18 (Ver. 13) |
| Basic information | ||
| Public title | Evaluation of limb muscle and diaphragm atrophy in critically ill patients | |
| Acronym | Limb muscle and diaphragm atrophy | |
| Scientific Title | Evaluation of limb muscle and diaphragm atrophy in critically ill patients | |
| Scientific Title:Acronym | Limb muscle and diaphragm atrophy | |
| Region |
|
|
| Condition | |||
| Condition | Patients admitted in the ICU | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Evaluation of limbs muscle and diaphragm atrophy |
| Basic objectives2 | Others |
| Basic objectives -Others | Evaluate limb muscle and diaphragm atrophy and functional disabilities to improve nutrition and rehabilitation management in the critically ill patients. |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The change of thickness and cross-sectional area about limb muscle and diaphragm on days 1, 2, 3, 5, 7,and 10 with serial ultrasonographic measurements after ICU admission |
| Key secondary outcomes | The change of following several parameters on days 1, 2, 3, 5, 7, and 10 after ICU admission
Muscle strength by MRC score Muscle strength by hand dynamometer Thickening fraction of diaphragm by ultrasonography The change of intercostal muscle thickness by ultrasonography Texture analysis of limb and diaphragm muscle by ultrasonography Muscle mass by bioelectrical impedance analysis FSS-ICU and ICU mobility Scale Titin in urine Biomarker in urine and blood |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | We consecutively recruited adult patients who were expected to remain in the ICU more than 3 days. | |||
| Key exclusion criteria | We excluded patients who fell under one or more of the following categories: exhibiting trauma to or amputation of limbs; diagnosed with primary neuromuscular disease. | |||
| Target sample size | 106 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tokushima university hospital | ||||||
| Division name | Emergency and critical care medicine | ||||||
| Zip code | 770-8503 | ||||||
| Address | 2-50-1, Kuramoto, Tokushima 770-8503, Japan | ||||||
| TEL | 088-633-9347 | ||||||
| nobuto_nakanishi@yahoo.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tokushima university hospital | ||||||
| Division name | Emergency and critical care medicine | ||||||
| Zip code | 770-8503 | ||||||
| Address | 2-50-1, Kuramoto, Tokushima 770-8503, Japan | ||||||
| TEL | 088-633-9347 | ||||||
| Homepage URL | |||||||
| nobuto_nakanishi@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Tokushima university hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Tokushima prefectural central hospital |
| Name of secondary funder(s) | None |
| IRB Contact (For public release) | |
| Organization | Clinical Trial Center for Developmental therapeutics, Tokushima University Hospital |
| Address | 2-50-1 Kuramoto, Tokushima 770-8503, Japan |
| Tel | 088-633-9294 |
| awachiken@tokushima-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | 2593 |
| Org. issuing International ID_1 | Tokushima university hospital |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 徳島大学病院、徳島県立中央病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |||||||
| URL related to results and publications | https://www.ncbi.nlm.nih.gov/pubmed/29110031 | ||||||
| Number of participants that the trial has enrolled | 28 | ||||||
| Results | Biceps brachii thickness and cross-sectional area decreased by 6.5, 11.0, and 13.2% (p < 0.01), and by 8.3, 11.1 and 16.9% on day 3, 5, and 7 (p < 0.01), respectively (Fig. 1). Rectus femoris thickness and cross-sectional area decreased by 7.4, 11.1, and 18.8%, and by 8.7, 13.7, and 20.7% on days 3, 5, and 7 (p < 0.01), respectively. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | Twenty eight patients were enrolled. The mean age was 68 years, 18 males, and median APACHE II score 27.5 (23.0 to 29.3). |
||||||
| Participant flow | |||||||
| Adverse events | None |
||||||
| Outcome measures | The muscle mass of the biceps brachii and rectus femoris were evaluated |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Muscle mass and function are valuated on days 1, 3, 5, 7, and 10 after ICU admission. We use ultrasonography, hand dynamometer, urinary titin, biomarkers in urine and blood, and Bioelectrical impedance analysis. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000035747 |